MGLIX
Price
$15.77
Change
+$0.13 (+0.83%)
Updated
Apr 24 closing price
Net Assets
2.19B
RRSCX
Price
$26.23
Change
+$0.12 (+0.46%)
Updated
Apr 24 closing price
Net Assets
358.64M
Ad is loading...

MGLIX vs RRSCX

Header iconMGLIX vs RRSCX Comparison
Open Charts MGLIX vs RRSCXBanner chart's image
MFS Global Real Estate I
Price$15.77
Change+$0.13 (+0.83%)
VolumeN/A
Net Assets2.19B
Russell Inv Global Real Estate Secs C
Price$26.23
Change+$0.12 (+0.46%)
VolumeN/A
Net Assets358.64M
MGLIX vs RRSCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGLIX vs. RRSCX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLIX is a Buy and RRSCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.19B vs. RRSCX (359M). MGLIX pays higher dividends than RRSCX: MGLIX (2.61) vs RRSCX (2.13). MGLIX was incepted earlier than RRSCX: MGLIX (16 years) vs RRSCX (26 years). RRSCX (2.17) is less costly to investors than MGLIX (0.95). RRSCX is a more actively managed with annual turnover of: 70.00 vs. MGLIX (48.00). MGLIX (0) and RRSCX (0) have matching initial minimum investment requirements. RRSCX annual gain was more profitable for investors over the last year : 7.62 vs. MGLIX (2.35). MGLIX return over 5 years is better than : 21.58 vs. RRSCX (19.13).
MGLIXRRSCXMGLIX / RRSCX
Total Expense Ratio0.942.0945%
Annual Report Gross Expense Ratio0.952.1744%
Fund Existence16 years26 years-
Gain YTD-2.4940.426-585%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.19B359M610%
Annual Yield % from dividends2.612.13123%
Returns for 1 year2.357.6231%
Returns for 3 years-21.16-15.81134%
Returns for 5 years21.5819.13113%
Returns for 10 years19.21-15.20-126%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX43.02N/A
N/A
Tocqueville
JFNAX63.90N/A
N/A
Janus Henderson Global Life Sciences A
GMVRX14.37N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.22N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.14N/A
N/A
Invesco EQV Emerging Markets All Cap R5